Curis, Inc.
CRIS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.02 | 0.00 | 0.02 |
| FCF Yield | -21.40% | -27.34% | -40.66% | -39.45% |
| EV / EBITDA | -2.74 | -6.29 | -0.02 | -0.73 |
| Quality | ||||
| ROIC | -77.30% | -41.79% | -49.52% | -38.15% |
| Gross Margin | 0.00% | 99.42% | 99.41% | 99.01% |
| Cash Conversion Ratio | 0.72 | 0.93 | 0.68 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.48% | 3.77% | 2.50% | 2.39% |
| Free Cash Flow Growth | 30.47% | -10.44% | 21.68% | -56.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.02 | -2.72 | 1.75 | 1.95 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -14.62 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 91.90 | -22,955.53 | -32,723.89 | -15,919.30 |